Multidrug-Resistant <i>Acinetobacter baumannii</i> Genetic Characterization and Spread in Lithuania in 2014, 2016, and 2018

Multidrug-Resistant <i>Acinetobacter baumannii</i> Genetic Characterization and Spread in Lithuania in 2014, 2016, and 2018

Bacterial resistance to antimicrobial agents plays an important role in the treatment of bacterial infections in healthcare institutions. The spread of multidrug-resistant bacteria can occur during inter- and intra-hospital transmissions among patients and hospital personnel. For this reason, more s...

Full description

Bibliographic Details
Main Authors:	Tatjana Kirtikliene, Aistė Mierauskaitė, Ilona Razmienė, Nomeda Kuisiene
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Life
Subjects:	multidrug resistance nosocomial infections <i>Acinetobacter baumannii</i> MLVA-8 resistance genes
Online Access:	https://www.mdpi.com/2075-1729/11/2/151

Similar Items

Genetic Characterization of Multidrug-Resistant <i>E. coli</i> Isolates from Bloodstream Infections in Lithuania
by: Tatjana Kirtikliene, et al.
Published: (2022-02-01)

Antibiotic Resistance and Genotypes of Nosocomial Strains of <i>Acinetobacter baumannii</i> in Kazakhstan
by: Alyona Lavrinenko, et al.
Published: (2021-04-01)

Multidrug-Resistant Acinetobacter baumannii
by: Aharon Abbo, et al.
Published: (2005-01-01)

Study of Incidence, Risk Factors and Antibiotic Sensitivity Pattern of Acinetobacter baumannii in a Tertiary Care Hospital
by: Vijaya S Rajmane, et al.
Published: (2015-01-01)

Recent Progress in Phage Therapy to Modulate Multidrug-Resistant <i>Acinetobacter baumannii</i>, including in Human and Poultry
by: Yan Zhang, et al.
Published: (2022-10-01)

Antibiotic resistance pattern of Acinetobacter baumannii strains: A retrospective study from Oman
by: Mohan B Sannathimmappa, et al.
Published: (2021-01-01)

The Anti-Multidrug-Resistant <i>Acinetobacter baumannii</i> Study on 1,3-diamino-7H-pyrrolo[3,2-f]quinazoline Compounds
by: Han Wu, et al.
Published: (2022-12-01)

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022-09-01)

<i>Acinetobacter baumannii</i> Antibiotic Resistance Mechanisms
by: Ioannis Kyriakidis, et al.
Published: (2021-03-01)

Investigating Bacteriophages Targeting the Opportunistic Pathogen <i>Acinetobacter baumannii</i>
by: Kathryn M. Styles, et al.
Published: (2020-04-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Isolation of bacteriophages against multidrug resistant Acinetobacter baumannii
by: Hasan Ghajavand, et al.
Published: (2017-01-01)

The Prevalence of Multidrug-Resistant <i>Acinetobacter baumannii</i> and Its Vaccination Status among Healthcare Providers
by: Ayman Elbehiry, et al.
Published: (2023-06-01)

Prevalence of antibiotic-resistant <i>Acinetobacter baumannii</i> in a 1000-bed tertiary care hospital in Tehran, Iran
by: Rahbar Mohammad, et al.
Published: (2010-04-01)

Gram-Negative Bacteria Holding Together in a Biofilm: The <i>Acinetobacter baumannii</i> Way
by: Arianna Pompilio, et al.
Published: (2021-06-01)

Acinetobacter baumannii Infection in the Neonatal Intensive Care Unit
by: AMK Jarousha, et al.
Published: (2008-09-01)

Acinetobacter baumannii Infection in the Neonatal Intensive Care Unit
by: AMK AL Jarousha, et al.
Published: (2008-09-01)

GATR-3, a Peptide That Eradicates Preformed Biofilms of Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Monique L. van Hoek, et al.
Published: (2023-12-01)

Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin
by: Yu-Mu Chen, et al.
Published: (2014-10-01)

Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant <i>Acinetobacter baumannii</i>
by: E. H. T. Thulshan Jayathilaka, et al.
Published: (2022-07-01)

Colistin Monotherapy versus Colistin plus Meropenem Combination Therapy for the Treatment of Multidrug-Resistant <i>Acinetobacter baumannii</i> Infection: A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022-06-01)

Bacteriophages as therapeutic & disinfectant agents to tackle multidrug-resistant Acinetobacter baumannii
by: Nisha Rathor, et al.
Published: (2023-01-01)

Factors influencing survival in patients with multidrug-resistant Acinetobacter baumannii infection
by: Mariana Lima Prata-Rocha, et al.

Multidrug-Resistant Acinetobacter baumannii Osteomyelitis from Iraq
by: Jason J. Schafer, et al.
Published: (2008-03-01)

A bronchofiberoscopy-associated outbreak of multidrug-resistant <it>Acinetobacter baumannii</it> in an intensive care unit in Beijing, China
by: Xia Yukun, et al.
Published: (2012-12-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

Epidemiological characteristics of multidrug-resistant Acinetobacter baumannii ST369 in Anhui, China
by: Yi Huang, et al.
Published: (2023-10-01)

Meta-analysis study for antibiotic resistance of Acinetobacter baumannii clinical isolates
by: Masoud Keikha, et al.
Published: (2017-06-01)

The Antimicrobial Peptide Octopromycin Suppresses Biofilm Formation and Quorum Sensing in <i>Acinetobacter baumannii</i>
by: Dinusha Chathurangi Rajapaksha, et al.
Published: (2023-03-01)

Virulence Characteristics and Emerging Therapies for Biofilm-Forming <i>Acinetobacter baumannii</i>: A Review
by: Karma G. Dolma, et al.
Published: (2022-09-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

Genotypic patterns of multidrug-resistant Acinetobacter baumannii: A systematic review
by: Golnar Rahimzadeh, et al.
Published: (2023-01-01)

Control of Healthcare-Associated Carbapenem-Resistant <i>Acinetobacter baumannii</i> by Enhancement of Infection Control Measures
by: Shuk-Ching Wong, et al.
Published: (2022-08-01)

Molecular Characterization of Multiple Antibiotic-Resistant Acinetobacter baumannii Isolated from Egyptian Patients
by: Aya A. Khodier, et al.
Published: (2020-12-01)

Effect of Phenylalanine–Arginine Beta-Naphthylamide on the Values of Minimum Inhibitory Concentration of Quinolones and Aminoglycosides in Clinical Isolates of <i>Acinetobacter baumannii</i>
by: Stefany Plasencia-Rebata, et al.
Published: (2023-06-01)

Multidrug-Resistant <i>Acinetobacter baumannii</i> in Jordan
by: Mohammad Al-Tamimi, et al.
Published: (2022-04-01)

Insights into <i>Acinetobacter baumannii</i>: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen
by: Carole Ayoub Moubareck, et al.
Published: (2020-03-01)

Synergistic Effects of a Probiotic Culture Extract and Antimicrobial Combinations against Multidrug-Resistant <i>Acinetobacter baumannii</i>
by: Ji Hyeon Lee, et al.
Published: (2023-05-01)

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against <i>Acinetobacter baumannii</i> Strains Recovered from Clinical Samples
by: Davide Carcione, et al.
Published: (2021-10-01)

<i>Acinetobacter baumannii</i> Resistance: A Real Challenge for Clinicians
by: Rosalino Vázquez-López, et al.
Published: (2020-04-01)